Blog Archive

Do you qualify for Wegovy or Rezdiffra for MASH with liver fibrosis stage F2 or F3? Aug 19th, 2025

The FDA has just approved Wegovy for liver fibrosis stages F2 or F3 becoming the second approved medication after Rezdiffra which we have already been using to treat patients with liver fibrosis identified on the guideline-required Fibroscan liver ultrasound provided in our office. We are one of the first primary...